Publication | Closed Access

Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma

Epigenetic SilencingNeuro-oncologyNon-alkylating AgentMedicineEpigenetic ChangeAnti-cancer AgentHigh-grade GliomasCell BiologyCancer TreatmentRadiation OncologyCancer BiologyGliomaCancer ResearchTumor MicroenvironmentTumor BiologyNovel Therapeutic Approach